Stephanie Ducas, PharmD
Orlando, Fla.—A pharmacist-driven stewardship initiative based on data mining of electronic health records (EHRs) significantly reduced prescribing of ceftaroline (Teflaro, Forest/Takeda), according to a study presented at the Making a Difference in Infectious Diseases (MAD-ID) conference.
Although the antibiotic has many benefits for selected patients, its broad spectrum of activity and other characteristics make it a suboptimal match for some